ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global IVD Antibody Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-19G13451
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global IVD Antibody Market Research Report 2023
BUY CHAPTERS

Global IVD Antibody Market Research Report 2025

Code: QYRE-Auto-19G13451
Report
March 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abcam
R&D Systems
Cell Signaling Technology
Affymatrix
BioLegend
Beckman Coulter
Santa Cruz Biotechnologies
Roche/Ventana
BD PharMingen

IVD Antibody Market Size

The global market for IVD Antibody was valued at US$ 932 million in the year 2024 and is projected to reach a revised size of US$ 1585 million by 2031, growing at a CAGR of 8.0% during the forecast period.

IVD Antibody Market

IVD Antibody Market

IVD Antibody
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for IVD Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IVD Antibody.
The IVD Antibody market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global IVD Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IVD Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of IVD Antibody Market Report

Report Metric Details
Report Name IVD Antibody Market
Accounted market size in year US$ 932 million
Forecasted market size in 2031 US$ 1585 million
CAGR 8.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • RIA
  • ELISA
  • CLIA
  • LFIA
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company BD PharMingen, Abcam, R&D Systems, Cell Signaling Technology, Affymatrix, BioLegend, Santa Cruz Biotechnologies, Beckman Coulter, Roche/Ventana
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of IVD Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of IVD Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is IVD Antibody Market growing?

Ans: The IVD Antibody Market witnessing a CAGR of 8.0% during the forecast period 2025-2031.

What is the IVD Antibody Market size in 2031?

Ans: The IVD Antibody Market size in 2031 will be US$ 1585 million.

Who are the main players in the IVD Antibody Market report?

Ans: The main players in the IVD Antibody Market are BD PharMingen, Abcam, R&D Systems, Cell Signaling Technology, Affymatrix, BioLegend, Santa Cruz Biotechnologies, Beckman Coulter, Roche/Ventana

What are the Application segmentation covered in the IVD Antibody Market report?

Ans: The Applications covered in the IVD Antibody Market report are RIA, ELISA, CLIA, LFIA, Other

What are the Type segmentation covered in the IVD Antibody Market report?

Ans: The Types covered in the IVD Antibody Market report are mAb, pAb, rAbs

Recommended Reports

IVD Diagnostics Market

Immunotherapy & Drugs

Livestock & Vaccine Markets

1 IVD Antibody Market Overview
1.1 Product Definition
1.2 IVD Antibody by Type
1.2.1 Global IVD Antibody Market Value Comparison by Type (2024 VS 2031)
1.2.2 mAb
1.2.3 pAb
1.2.4 rAbs
1.3 IVD Antibody by Application
1.3.1 Global IVD Antibody Market Value by Application (2024 VS 2031)
1.3.2 RIA
1.3.3 ELISA
1.3.4 CLIA
1.3.5 LFIA
1.3.6 Other
1.4 Global IVD Antibody Market Size Estimates and Forecasts
1.4.1 Global IVD Antibody Revenue 2020-2031
1.4.2 Global IVD Antibody Sales 2020-2031
1.4.3 Global IVD Antibody Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 IVD Antibody Market Competition by Manufacturers
2.1 Global IVD Antibody Sales Market Share by Manufacturers (2020-2025)
2.2 Global IVD Antibody Revenue Market Share by Manufacturers (2020-2025)
2.3 Global IVD Antibody Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of IVD Antibody, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of IVD Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of IVD Antibody, Product Type & Application
2.7 Global Key Manufacturers of IVD Antibody, Date of Enter into This Industry
2.8 Global IVD Antibody Market Competitive Situation and Trends
2.8.1 Global IVD Antibody Market Concentration Rate
2.8.2 The Global 5 and 10 Largest IVD Antibody Players Market Share by Revenue
2.8.3 Global IVD Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global IVD Antibody Market Scenario by Region
3.1 Global IVD Antibody Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global IVD Antibody Sales by Region: 2020-2031
3.2.1 Global IVD Antibody Sales by Region: 2020-2025
3.2.2 Global IVD Antibody Sales by Region: 2026-2031
3.3 Global IVD Antibody Revenue by Region: 2020-2031
3.3.1 Global IVD Antibody Revenue by Region: 2020-2025
3.3.2 Global IVD Antibody Revenue by Region: 2026-2031
3.4 North America IVD Antibody Market Facts & Figures by Country
3.4.1 North America IVD Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America IVD Antibody Sales by Country (2020-2031)
3.4.3 North America IVD Antibody Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe IVD Antibody Market Facts & Figures by Country
3.5.1 Europe IVD Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe IVD Antibody Sales by Country (2020-2031)
3.5.3 Europe IVD Antibody Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific IVD Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific IVD Antibody Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific IVD Antibody Sales by Region (2020-2031)
3.6.3 Asia Pacific IVD Antibody Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America IVD Antibody Market Facts & Figures by Country
3.7.1 Latin America IVD Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America IVD Antibody Sales by Country (2020-2031)
3.7.3 Latin America IVD Antibody Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa IVD Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa IVD Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa IVD Antibody Sales by Country (2020-2031)
3.8.3 Middle East and Africa IVD Antibody Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global IVD Antibody Sales by Type (2020-2031)
4.1.1 Global IVD Antibody Sales by Type (2020-2025)
4.1.2 Global IVD Antibody Sales by Type (2026-2031)
4.1.3 Global IVD Antibody Sales Market Share by Type (2020-2031)
4.2 Global IVD Antibody Revenue by Type (2020-2031)
4.2.1 Global IVD Antibody Revenue by Type (2020-2025)
4.2.2 Global IVD Antibody Revenue by Type (2026-2031)
4.2.3 Global IVD Antibody Revenue Market Share by Type (2020-2031)
4.3 Global IVD Antibody Price by Type (2020-2031)
5 Segment by Application
5.1 Global IVD Antibody Sales by Application (2020-2031)
5.1.1 Global IVD Antibody Sales by Application (2020-2025)
5.1.2 Global IVD Antibody Sales by Application (2026-2031)
5.1.3 Global IVD Antibody Sales Market Share by Application (2020-2031)
5.2 Global IVD Antibody Revenue by Application (2020-2031)
5.2.1 Global IVD Antibody Revenue by Application (2020-2025)
5.2.2 Global IVD Antibody Revenue by Application (2026-2031)
5.2.3 Global IVD Antibody Revenue Market Share by Application (2020-2031)
5.3 Global IVD Antibody Price by Application (2020-2031)
6 Key Companies Profiled
6.1 BD PharMingen
6.1.1 BD PharMingen Company Information
6.1.2 BD PharMingen Description and Business Overview
6.1.3 BD PharMingen IVD Antibody Sales, Revenue and Gross Margin (2020-2025)
6.1.4 BD PharMingen IVD Antibody Product Portfolio
6.1.5 BD PharMingen Recent Developments/Updates
6.2 Abcam
6.2.1 Abcam Company Information
6.2.2 Abcam Description and Business Overview
6.2.3 Abcam IVD Antibody Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Abcam IVD Antibody Product Portfolio
6.2.5 Abcam Recent Developments/Updates
6.3 R&D Systems
6.3.1 R&D Systems Company Information
6.3.2 R&D Systems Description and Business Overview
6.3.3 R&D Systems IVD Antibody Sales, Revenue and Gross Margin (2020-2025)
6.3.4 R&D Systems IVD Antibody Product Portfolio
6.3.5 R&D Systems Recent Developments/Updates
6.4 Cell Signaling Technology
6.4.1 Cell Signaling Technology Company Information
6.4.2 Cell Signaling Technology Description and Business Overview
6.4.3 Cell Signaling Technology IVD Antibody Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cell Signaling Technology IVD Antibody Product Portfolio
6.4.5 Cell Signaling Technology Recent Developments/Updates
6.5 Affymatrix
6.5.1 Affymatrix Company Information
6.5.2 Affymatrix Description and Business Overview
6.5.3 Affymatrix IVD Antibody Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Affymatrix IVD Antibody Product Portfolio
6.5.5 Affymatrix Recent Developments/Updates
6.6 BioLegend
6.6.1 BioLegend Company Information
6.6.2 BioLegend Description and Business Overview
6.6.3 BioLegend IVD Antibody Sales, Revenue and Gross Margin (2020-2025)
6.6.4 BioLegend IVD Antibody Product Portfolio
6.6.5 BioLegend Recent Developments/Updates
6.7 Santa Cruz Biotechnologies
6.7.1 Santa Cruz Biotechnologies Company Information
6.7.2 Santa Cruz Biotechnologies Description and Business Overview
6.7.3 Santa Cruz Biotechnologies IVD Antibody Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Santa Cruz Biotechnologies IVD Antibody Product Portfolio
6.7.5 Santa Cruz Biotechnologies Recent Developments/Updates
6.8 Beckman Coulter
6.8.1 Beckman Coulter Company Information
6.8.2 Beckman Coulter Description and Business Overview
6.8.3 Beckman Coulter IVD Antibody Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Beckman Coulter IVD Antibody Product Portfolio
6.8.5 Beckman Coulter Recent Developments/Updates
6.9 Roche/Ventana
6.9.1 Roche/Ventana Company Information
6.9.2 Roche/Ventana Description and Business Overview
6.9.3 Roche/Ventana IVD Antibody Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Roche/Ventana IVD Antibody Product Portfolio
6.9.5 Roche/Ventana Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 IVD Antibody Industry Chain Analysis
7.2 IVD Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 IVD Antibody Production Mode & Process Analysis
7.4 IVD Antibody Sales and Marketing
7.4.1 IVD Antibody Sales Channels
7.4.2 IVD Antibody Distributors
7.5 IVD Antibody Customer Analysis
8 IVD Antibody Market Dynamics
8.1 IVD Antibody Industry Trends
8.2 IVD Antibody Market Drivers
8.3 IVD Antibody Market Challenges
8.4 IVD Antibody Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Abcam
R&D Systems
Cell Signaling Technology
Affymatrix
BioLegend
Beckman Coulter
Santa Cruz Biotechnologies
Roche/Ventana
BD PharMingen
List of Tables
 Table 1. Global IVD Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global IVD Antibody Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global IVD Antibody Market Competitive Situation by Manufacturers in 2024
 Table 4. Global IVD Antibody Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global IVD Antibody Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global IVD Antibody Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global IVD Antibody Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market IVD Antibody Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of IVD Antibody, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of IVD Antibody, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of IVD Antibody, Product Type & Application
 Table 12. Global Key Manufacturers of IVD Antibody, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global IVD Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Antibody as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global IVD Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global IVD Antibody Sales by Region (2020-2025) & (K Units)
 Table 18. Global IVD Antibody Sales Market Share by Region (2020-2025)
 Table 19. Global IVD Antibody Sales by Region (2026-2031) & (K Units)
 Table 20. Global IVD Antibody Sales Market Share by Region (2026-2031)
 Table 21. Global IVD Antibody Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global IVD Antibody Revenue Market Share by Region (2020-2025)
 Table 23. Global IVD Antibody Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global IVD Antibody Revenue Market Share by Region (2026-2031)
 Table 25. North America IVD Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America IVD Antibody Sales by Country (2020-2025) & (K Units)
 Table 27. North America IVD Antibody Sales by Country (2026-2031) & (K Units)
 Table 28. North America IVD Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America IVD Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe IVD Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe IVD Antibody Sales by Country (2020-2025) & (K Units)
 Table 32. Europe IVD Antibody Sales by Country (2026-2031) & (K Units)
 Table 33. Europe IVD Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe IVD Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific IVD Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific IVD Antibody Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific IVD Antibody Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific IVD Antibody Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific IVD Antibody Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America IVD Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America IVD Antibody Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America IVD Antibody Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America IVD Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America IVD Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa IVD Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa IVD Antibody Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa IVD Antibody Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa IVD Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa IVD Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global IVD Antibody Sales (K Units) by Type (2020-2025)
 Table 51. Global IVD Antibody Sales (K Units) by Type (2026-2031)
 Table 52. Global IVD Antibody Sales Market Share by Type (2020-2025)
 Table 53. Global IVD Antibody Sales Market Share by Type (2026-2031)
 Table 54. Global IVD Antibody Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global IVD Antibody Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global IVD Antibody Revenue Market Share by Type (2020-2025)
 Table 57. Global IVD Antibody Revenue Market Share by Type (2026-2031)
 Table 58. Global IVD Antibody Price (US$/Unit) by Type (2020-2025)
 Table 59. Global IVD Antibody Price (US$/Unit) by Type (2026-2031)
 Table 60. Global IVD Antibody Sales (K Units) by Application (2020-2025)
 Table 61. Global IVD Antibody Sales (K Units) by Application (2026-2031)
 Table 62. Global IVD Antibody Sales Market Share by Application (2020-2025)
 Table 63. Global IVD Antibody Sales Market Share by Application (2026-2031)
 Table 64. Global IVD Antibody Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global IVD Antibody Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global IVD Antibody Revenue Market Share by Application (2020-2025)
 Table 67. Global IVD Antibody Revenue Market Share by Application (2026-2031)
 Table 68. Global IVD Antibody Price (US$/Unit) by Application (2020-2025)
 Table 69. Global IVD Antibody Price (US$/Unit) by Application (2026-2031)
 Table 70. BD PharMingen Company Information
 Table 71. BD PharMingen Description and Business Overview
 Table 72. BD PharMingen IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. BD PharMingen IVD Antibody Product
 Table 74. BD PharMingen Recent Developments/Updates
 Table 75. Abcam Company Information
 Table 76. Abcam Description and Business Overview
 Table 77. Abcam IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Abcam IVD Antibody Product
 Table 79. Abcam Recent Developments/Updates
 Table 80. R&D Systems Company Information
 Table 81. R&D Systems Description and Business Overview
 Table 82. R&D Systems IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. R&D Systems IVD Antibody Product
 Table 84. R&D Systems Recent Developments/Updates
 Table 85. Cell Signaling Technology Company Information
 Table 86. Cell Signaling Technology Description and Business Overview
 Table 87. Cell Signaling Technology IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Cell Signaling Technology IVD Antibody Product
 Table 89. Cell Signaling Technology Recent Developments/Updates
 Table 90. Affymatrix Company Information
 Table 91. Affymatrix Description and Business Overview
 Table 92. Affymatrix IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Affymatrix IVD Antibody Product
 Table 94. Affymatrix Recent Developments/Updates
 Table 95. BioLegend Company Information
 Table 96. BioLegend Description and Business Overview
 Table 97. BioLegend IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. BioLegend IVD Antibody Product
 Table 99. BioLegend Recent Developments/Updates
 Table 100. Santa Cruz Biotechnologies Company Information
 Table 101. Santa Cruz Biotechnologies Description and Business Overview
 Table 102. Santa Cruz Biotechnologies IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Santa Cruz Biotechnologies IVD Antibody Product
 Table 104. Santa Cruz Biotechnologies Recent Developments/Updates
 Table 105. Beckman Coulter Company Information
 Table 106. Beckman Coulter Description and Business Overview
 Table 107. Beckman Coulter IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Beckman Coulter IVD Antibody Product
 Table 109. Beckman Coulter Recent Developments/Updates
 Table 110. Roche/Ventana Company Information
 Table 111. Roche/Ventana Description and Business Overview
 Table 112. Roche/Ventana IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Roche/Ventana IVD Antibody Product
 Table 114. Roche/Ventana Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. IVD Antibody Distributors List
 Table 118. IVD Antibody Customers List
 Table 119. IVD Antibody Market Trends
 Table 120. IVD Antibody Market Drivers
 Table 121. IVD Antibody Market Challenges
 Table 122. IVD Antibody Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of IVD Antibody
 Figure 2. Global IVD Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global IVD Antibody Market Share by Type: 2024 & 2031
 Figure 4. mAb Product Picture
 Figure 5. pAb Product Picture
 Figure 6. rAbs Product Picture
 Figure 7. Global IVD Antibody Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global IVD Antibody Market Share by Application: 2024 & 2031
 Figure 9. RIA
 Figure 10. ELISA
 Figure 11. CLIA
 Figure 12. LFIA
 Figure 13. Other
 Figure 14. Global IVD Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global IVD Antibody Market Size (2020-2031) & (US$ Million)
 Figure 16. Global IVD Antibody Sales (2020-2031) & (K Units)
 Figure 17. Global IVD Antibody Average Price (US$/Unit) & (2020-2031)
 Figure 18. IVD Antibody Report Years Considered
 Figure 19. IVD Antibody Sales Share by Manufacturers in 2024
 Figure 20. Global IVD Antibody Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest IVD Antibody Players: Market Share by Revenue in IVD Antibody in 2024
 Figure 22. IVD Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global IVD Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America IVD Antibody Sales Market Share by Country (2020-2031)
 Figure 25. North America IVD Antibody Revenue Market Share by Country (2020-2031)
 Figure 26. United States IVD Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada IVD Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe IVD Antibody Sales Market Share by Country (2020-2031)
 Figure 29. Europe IVD Antibody Revenue Market Share by Country (2020-2031)
 Figure 30. Germany IVD Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France IVD Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. IVD Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy IVD Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia IVD Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific IVD Antibody Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific IVD Antibody Revenue Market Share by Region (2020-2031)
 Figure 37. China IVD Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan IVD Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea IVD Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India IVD Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia IVD Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan IVD Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia IVD Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand IVD Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia IVD Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America IVD Antibody Sales Market Share by Country (2020-2031)
 Figure 47. Latin America IVD Antibody Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico IVD Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil IVD Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina IVD Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa IVD Antibody Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa IVD Antibody Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey IVD Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia IVD Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE IVD Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of IVD Antibody by Type (2020-2031)
 Figure 57. Global Revenue Market Share of IVD Antibody by Type (2020-2031)
 Figure 58. Global IVD Antibody Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of IVD Antibody by Application (2020-2031)
 Figure 60. Global Revenue Market Share of IVD Antibody by Application (2020-2031)
 Figure 61. Global IVD Antibody Price (US$/Unit) by Application (2020-2031)
 Figure 62. IVD Antibody Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global IVD Antibodies Market Insights Forecast to 2030
Global Primary Immunodeficiency Drug Market Research Report 2025
Global PD 1 and PD L1 Antibody Market Insights Forecast to 2030
Global Valacyclovir Market Research Report 2024
Veterinary Medicines and Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global In Vitro Diagnostics IVD Quality Control Product Market Insights Forecast to 2030
Global Anti PD 1 MAb Market Insights Forecast to 2030
Global Antibody Engineering Services Market Insights Forecast to 2030
Global Plasma ELISA Kit Market Research Report 2025
Global Myoglobin Test Market Insights Forecast to 2030
Global Myoglobgin Test Market Insights Forecast to 2030
Bovine Medicine and Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Angioedema Treatment Market Insights Forecast to 2030
Global AVoIP Market Insights Forecast to 2030
Global PVALB Test Market Insights Forecast to 2030
Bovine Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human Serum Albumin Test Market Insights Forecast to 2030
Global Research Antibodies Market Research Report 2025
Global AVoIP Protocol Market Insights Forecast to 2030
Intravenous Antibodies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions